Inactive Instrument

News Celsion Corporation Nasdaq

Equities

US15117N4043

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 18	Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine	MT
Apr. 18	Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine	Apr. 18	MT
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine	Apr. 18	DJ
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101	Apr. 18	AQ
Imunon, Inc. Application Cleared to Begin Human Testing of IMNN-101	Apr. 18	CI
IMUNON Reports Compliance with Nasdaq Listing Requirements	Apr. 11	AQ
HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating	Apr. 01	MT
Top Midday Gainers	Mar. 28	MT
Transcript : Imunon, Inc., Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
Imunon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
IMUNON Reports 2023 Financial Results and Provides Business Update	Mar. 28	AQ
North American Morning Briefing : Stocks Set for -2-	Mar. 28	DJ
IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses	Mar. 25	AQ
IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024	Mar. 21	AQ
IMUNON Files IND Application to Begin Human Testing of IMNN-101	Mar. 13	AQ
Imunon, Inc. Files Ind Application to Begin Human Testing of Imnn-101	Mar. 13	CI
IMUNON Names Executive Chairman as Temporary Head Following Resignation of CEO Corinne Le Goff	Mar. 13	MT
IMUNON Announces Leadership Change	Mar. 12	AQ
Imunon, Inc. Announces Executive Changes	Mar. 12	CI
Imunon, Inc. Announces Resignation of Corinne Le Goff as Chief Executive Officer, Effective March 15, 2024	Mar. 12	CI
Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5	Feb. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Celsion Corporation Nasdaq

Equities

US15117N4043

Summary

Filters